PERINATOLOGIYA I PEDIATRIYA.2016.1(65):118-121;doi 10.15574/PP.2016.65.118 
 

Modern aspects of the etiology and pathogenesis of the secondary myopathy in children with juvenile rheumatoid arthritis. Review of literature 
 

Dudnyk V. M., Bulavenko O. V., Vyzhga Yu. V.

Vinnitsa National Pirogov Memorial Medical University, Vinnitsa, Ukraine 
 

In the article presented modern knowledge concerning frequency and spread of the secondary myopathy in patients with rheumatic pathology especially juvenile rheumatoid arthritis. We provided analyze of the etiological and pathogenic aspects of the process and summarized trigger mechanisms of the muscle damage, pathways of its development. Presented results prove the plural influence on the development of the process inflammatory activity and uncomplete condition of the muscle elements on the origin of the secondary myopathy. 
 

Кey words: secondary myopathy, juvenile rheumatoid arthritis. 
 

REFERENCES

1. Yunus MB et al. 2009. A controlled study of primary fibromyalgia syndrome: clinical features and association with other functional syndromes. J Rheumatol. 16; Suppl 19: 62—69.

2. Chakrabarty S, Zoorob R. 2007. Fibromyalgia. Am Fam Physician. 76: 247—254. PMid:17695569

3. Kim S-H, Lee Y, Lee S, Mun CW. 2013. Evaluation of the Effectiveness of Pregabalin in Alleviating Pain Associated with Fibromyalgia: Using Functional Magnetic Resonance Imaging Study. PLoSone. 8(9): e74099. http://dx.doi.org/10.1371/journal.pone.0074099; PMid:24040178 PMCid:PMC3765321

4. Bellato E, Marini E, Castoldi F et al. 2012. Fibromyalgia syndrome: Etiology, Pathogenesis, Diagnosis, and Treatment. Pain Research and Treatment: 1—17. http://dx.doi.org/10.1155/2012/426130; PMid:23213512 PMCid:PMC3503476

5. Fietta P, Manganelli P. 2007. Fibromyalgia and psychiatric disorders. Acta Biomed. 78: 88—95. PMid:17933276

6. Goldenberg DL. 2011. Fibromyalgia syndrome. An emerging but controversial condition. JAMA. 257(20): 2782—2787. http://dx.doi.org/10.1001/jama.1987.03390200122026; http://dx.doi.org/10.1001/jama.257.20.2782

7. Goldenberg DL. 2014. Fibromyalgia, chronic fatigue syndrome, and myofascial syndrome. Curr Opin Rhematol. 6(2): 223—233. http://dx.doi.org/10.1097/00002281-199403000-00018

8. Mease P. 2015. Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. J Rheumatol Suppl. 75: 6—21.

9. Perrot S, Bouhassira D, Fermanian J. 2010. Development and validation of the Fibromyalgia Rapid Screening Tool (FiRST). Pain. 150(2): 250—256. http://dx.doi.org/10.1016/j.pain.2010.03.034; PMid:20488620

10. Simons DG. 2015. Muscle pain syndromes. American Physical Medicine. 54: 289—298.

11. Smith HS, Harri R, Clauw D. 2011. Fibromyalgia: An Afferent Processing Disorder Leading to a Complex Pain Generalized Syndrome. Pain Physician. 14: E217—E245. http://dx.doi.org/10.1016/b978-1-4377-2242-0.00058-4

12. Thieme K, Turk DC, Flor H. 2014. Comorbid Depression and Anxiety in Fibromyalgia Syndrome: Relationship to Somatic and Psychosocial Variables. Psychosomatic Medicine. 66: 837—844. http://dx.doi.org/10.1097/01.psy.0000146329.63158.40; PMid:15564347